TRT Tracker is a health utility app for managing peptide, TRT, and GLP-1 medication protocols on iOS and Android.
The App DNA
What makes this app unique?
Users hire the app to eliminate the manual error and cognitive load of tracking complex medication cycles and inventory via spreadsheets.
For Individuals managing peptide, TRT, HRT, or GLP-1 medication protocols who require precise dosing and inventory tracking.
What does it look like?
Key features
Calculates precise concentrations based on vial amount and water volume for syringe-specific dosing guidance.
Logs body regions and injection sides to provide rotation scores and rest tracking to prevent tissue damage.
Tracks vials, pens, and ampules with batch numbers, expiration dates, and usage status with low-stock alerts.
How much does it cost?
Freemium model gates advanced protocol management and inventory tracking behind a Pro subscription to drive conversion.
Velocity
Maintenance developmentopaqueShow more...
The app has released only two versions over a period of nearly two years, resulting in a cadence of approximately 0.02 releases per week. This frequency falls well below the threshold for active development, indicating a maintenance-only lifecycle. There is no evidence of new features or live-ops content in the observed data. Development appears to be sporadic and focused solely on stability or minor adjustments.
Who built it?
Dewayne Defoor
5 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for TRT Tracker
How's the Health & Fitness market?
TRT Tracker occupies a specialized medical-utility niche, currently maintaining a 1.0 rating on iOS with limited review volume. The lack of Android-side rating data suggests a nascent market presence that requires immediate feature parity to compete with broader health-tracking entrants.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for TRT Tracker
Where is it heading?
The health-tracking market is shifting toward automated, AI-driven data entry, which puts manual-entry apps like TRT Tracker at a disadvantage. The PM must pivot from basic protocol reminders to clinical-grade data reporting to justify the $4.99 price point against free, automated competitors.
- The 1.0 rating on iOS suggests early-stage stability issues, which will likely suppress new-user conversion until the next release.
- The recent Android launch expands the addressable market, allowing for broader user testing and feedback loops in the coming quarter.
The SWOT
- Reconstitution calculator provides syringe-specific dosing guidance
- Injection site rotation tracking prevents tissue damage
- B2B partnerships with peptide clinics for patient protocol adherence
- Wearable integration for symptom tracking
Next best moves
Integrate Google Health Connect because it is a standard feature in competing health apps → reduce manual entry friction
The counter-intuitive read
The app's manual logging requirement is a feature, not a bug…
Read the full takeFeature gaps
Google Health Connect integration (available in FlashSnack but absent here) +1
Since the last report: The app transitioned from a stability-recovery phase to a competitive-positioning phase, emphasizing the need for data integration to justify a new $4.99 price point.
Bottom line
TRT Tracker provides high-utility tools for medical protocol management, but the lack of data integration and high entry price limits its adoption, so the PM should prioritize Health Connect integration to reduce manual friction.
Unlock 3 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeReport last updated